DermTech develops and commercializes gene expression tests for diagnosis of dermatologic conditions, such as melanoma.
Business Model:
Revenue: $14.7M
Employees: 201-500
DermTech was acquired by
Bausch Health.
The acquisition happend on 2008-11-14.
Details of the transaction were not public
Address: 11099 N. Torrey Pines Road
City: La Jolla
State: CA
Zip: 92037
Country: US
DermTech develops and commercializes gene expression tests for diagnosis of dermatologic conditions, such as melanoma.
Contact Phone:
+18584504222
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
8/30/2019
Ticker Symbol:
DMTK
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2012 | Venture Round | $11.6M | 7/2015 | Equity | $583.6k | 10/2016 | Venture Round | $2.1M | 8/2019 | Venture Round | 1 | $4M |
HLM Venture Partners HLM Venture Partners HLM Venture Partners HLM Venture Partners |
3/2015 | Debt | $2.4M | 8/2013 | Unattributed | $5.8M |
|
4/2015 | Debt Financing | $2.4M | 10/2016 | Series C | $10M |
RTW Investments |
6/1998 | Venture Round | 1 | - |
Tech Coast Angels Tech Coast Angels |
1/2021 | Post-IPO Equity | $143.7M | 11/2015 | Venture Round | $4.3M | 11/2017 | Series C | $10M | 8/2013 | Series B | $5.6M | 3/2020 | Post-IPO Equity | $65M | 3/2008 | Venture Round | $11.2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|